BioHealth News Archive
Key lawmaker: ARPA-H won’t be part of NIH – STAT
WASHINGTON — A new research agency aimed at developing breakthrough medical technologies won’t be housed within the National Institutes of Health, a key lawmaker…
Read MoreFresh Off Best Year Ever, Lab Giant Alexandria To Venture Into New Territory
The leading developer of life sciences properties rode the industry's wave last year, recording 4.1M SF of leases signed between October and December, more than double its…
Read More
USP and WHO Renew Official Relations to Continue Strengthening the Global Medicines Supply Chain | LinkedIn
On Saturday, January 29, the World Health Organization (WHO) Executive Board approved the renewal of official relations with the United States Pharmacopeial Convention (USP)…
Read More
The Clues to the Next Variant Surge Are All Around Us
When scientists in South Africa noticed an uptick in Covid-19 cases in the Gauteng Province last November, they began investigating the source. These researchers…
Read More
2021 Global life sciences sector outlook | Deloitte
Navigating the pandemic has been an all-encompassing, once-in-a-lifetime challenge. Globally, life sciences companies responded with leadership and are emerging stronger. How will life sciences…
Read More
Altimmune Announces FDA Clearance Of Pemvidutide (ALT-801) IND For Obesity
January 31, 2022 at 7:00 AM EST Enrollment in 48-week Phase 2 clinical trial expected to begin in Q1 2022 GAITHERSBURG, Md., Jan. 31, 2022 (GLOBE…
Read More
Gain Therapeutics Announces Additional Details on its February 4th Virtual R&D Day
BETHESDA, Md., Jan. 31, 2022 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”), a biotechnology company transforming the drug discovery paradigm with structurally targeted…
Read More
MaxCyte Signs Strategic Platform License with Intima Bioscience to Advance Tumor Infiltrating Lymphocytes Programs
Intima Bioscience to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to accelerate the development of its solid tumor cell-therapy candidates NEW YORK and…
Read More
Opportunity: Entrepreneur-In-Residence Role with BioHealth Innovation, Inc. and NIH (2)
POSITION DESCRIPTION – Entrepreneur-In-Residence EIRs will work in collaboration with SEED to mentor innovators and provide guidance to help them de-risk the technical and…
Read More
How can your BioHealth business benefit from a review by BHI industry experts? Please register for our next Entrepreneur-In-Residence (EIR) day on Feb. 16th and find out.
These free 1:1 virtual sessions are an opportunity to discuss your company with experts in diagnostics, therapeutics, digital health and medical devices. If you’re…
Read More
BHI’s next EIR Feedback Day is February 16th
These free 1:1 virtual sessions are an opportunity to discuss your company with experts in diagnostics, therapeutics, digital health and medical devices. If you’re…
Read More
Novavax Submits Request to the U.S. FDA for Emergency Use Authorization of COVID-19 Vaccine
- NVX-CoV2373 demonstrated overall efficacy of ~90% in PREVENT-19 clinical trial conducted during the emergence of variant strains GAITHERSBURG, Md., Jan. 31, 2022 /PRNewswire/…
Read More
BioHealth Innovation Announces Updates to its Board of Directors
Board of Directors Elects New Chair, Vice-Chair, and Two New Members ROCKVILLE, MARYLAND, January 31, 2021 – The Board of Directors of BioHealth Innovation,…
Read More
Opportunity: Entrepreneur-In-Residence Role with BioHealth Innovation, Inc. and NIH
POSITION DESCRIPTION – Entrepreneur-In-Residence EIRs will work in collaboration with SEED to mentor innovators and provide guidance to help them de-risk the technical and…
Read More
5 Cities Emerging As Future Hubs For Life Sciences Development
The current boom in life sciences development mirrors the tech industry, especially geographically; there is an incredible concentration of jobs and investment in the top…
Read More